Elliotts B Injection
NDC Package 55792-007-10
Package Information
Elliotts B (sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate) injection is elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma. This formulation utilizes a injection delivery system. Marketed by Lukare Medical, Llc, this product is identified by NDC 55792-007 and is authorized under FDA application NDA020577.
Identification & Billing
Clinical Specifications
- Alkalinizing Activity - [MoA] (Mechanism of Action)
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 55792 - Lukare Medical, Llc
- 55792-007 - Elliotts B
- 55792-007-10 - 10 AMPULE in 1 BOX / 10 mL in 1 AMPULE (55792-007-01)
- 55792-007 - Elliotts B
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55792-007-10 identifies a specific commercial package of 10 ampule in 1 box / 10 ml in 1 ampule (55792-007-01) of Elliotts B, a human prescription drug labeled by Lukare Medical, Llc. This injection is formulated for intrathecal use and contains anhydrous dextrose; calcium chloride; magnesium sulfate, unspecified form; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lukare Medical, Llc on June 04, 2013. The current certification is valid through December 31, 2026.
How is this Lukare Medical, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55792000710. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.